Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R01AI153044-01A1
Grant search
Key facts
Disease
Lassa Haemorrhagic Fever, COVID-19…Start & end year
20212025Known Financial Commitments (USD)
$478,330Funder
National Institutes of Health (NIH)Principal Investigator
PROFESSOR Marc SuchardResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF CALIFORNIA LOS ANGELESResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY/ABSTRACT This proposal targets the design, development and distribution of Bayesian statistical methods and software to study the historical and real-time emergence of rapidly evolving pathogens, such as Ebola, human immun- odeï¬Âciency, inï¬Â'uenza, Lassa, SARS-CoV-2, West Nile, yellow fever and Zika viruses. The proposal exploits novel scalable data integration to equip us for large-scale epidemics and pandemics and help inform action- able public health policy. Our multidisciplinary team carries expertise across statistical thinking, data science, evolutionary biology and infectious diseases to leverage advancing sequencing technology and high-throughput biological experimentation that can characterize 1000s of pathogen genomes, phenotype measurements, eco- logical and clinical information from a single outbreak. Our chief innovations are three-fold. First, we will invent and implement scalable Bayesian phylodynamic techniques to integrate phenotypic measurements and study their correlated evolution with disease spread. Second, we will foster biologically-rich evolutionary models to map and understand heterogeneity in disease evolution through new efï¬Âcient algorithms. Third, we will develop high-dimensional and mixed-type phenotype models to link concerted viral genotype / phenotype changes using massively parallel computing. Although no competing software exists to integrate phenotype and sequence data at this scale, we will compare restricted cases of our models with reduced datasets to current state-of-the-art approaches to evaluate computational performance improvement and bias that these limitations inject using real- world examples. This proposal will deliver low-level toolbox libraries and user-friendly software for deployment across a rapidly expanding range of large-scale problems in statistics and medicine.